"Nootropic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. While no potent nootropic drugs have yet been accepted for general use, several are being actively investigated.
| Descriptor ID |
D018697
|
| MeSH Number(s) |
D27.505.954.427.637
|
| Concept/Terms |
Nootropic Agents- Nootropic Agents
- Agents, Nootropic
- Nootropics
- Cognitive Enhancers
- Enhancers, Cognitive
- Nootropic Drugs
- Drugs, Nootropic
|
Below are MeSH descriptors whose meaning is more general than "Nootropic Agents".
Below are MeSH descriptors whose meaning is more specific than "Nootropic Agents".
This graph shows the total number of publications written about "Nootropic Agents" by people in this website by year, and whether "Nootropic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nootropic Agents" by people in Profiles.
-
Prakapenka AV, Hiroi R, Quihuis AM, Carson C, Patel S, Berns-Leone C, Fox C, Sirianni RW, Bimonte-Nelson HA. Contrasting effects of individual versus combined estrogen and progestogen regimens as working memory load increases in middle-aged ovariectomized rats: one plus one does not equal two. Neurobiol Aging. 2018 04; 64:1-14.
-
Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015 Apr; 14(4):388-405.
-
Loukavenko EA, Wolff M, Poirier GL, Dalrymple-Alford JC. Impaired spatial working memory after anterior thalamic lesions: recovery with cerebrolysin and enrichment. Brain Struct Funct. 2016 05; 221(4):1955-70.
-
Molas S, Gener T, G?ell J, Mart?n M, Ballesteros-Y??ez I, Sanchez-Vives MV, Dierssen M. Hippocampal changes produced by overexpression of the human CHRNA5/A3/B4 gene cluster may underlie cognitive deficits rescued by nicotine in transgenic mice. Acta Neuropathol Commun. 2014 Nov 11; 2:147.
-
Chapman RM, Porsteinsson AP, Gardner MN, Mapstone M, McCrary JW, Sandoval TC, Guillily MD, Reilly LA, DeGrush E. The impact of AD drug treatments on event-related potentials as markers of disease conversion. Curr Alzheimer Res. 2013 Sep; 10(7):732-41.
-
Gasper MC, Ott BR, Lapane KL. Is donepezil therapy associated with reduced mortality in nursing home residents with dementia? Am J Geriatr Pharmacother. 2005 Mar; 3(1):1-7.
-
Pedone C, Lapane KL, Mor V, Bernabei R. Donepezil use in US nursing homes. Aging Clin Exp Res. 2004 Feb; 16(1):60-7.